ENDRA LIFE SCIENCES INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • March 28th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • Delaware
THIS RESTRICTED STOCK AGREEMENT (this “Agreement”) is made as of November 30, 2023 (the “Effective Date”) by and between ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), and PatentVest, Inc. (“Recipient”). The 202,020 shares of the Company’s common stock (“Common Stock”) issued to you pursuant hereto are subject to the terms of this Agreement and the Consulting Services Agreement, dated as of November 30, 2023, by and between the Company and you (the “Services Agreement”), and are referred to herein as the “Restricted Stock”.
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • March 28th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus
PatentVest will perform certain of the Consulting Services generally described below in the Summary and Schedule. The Original Scope of Consulting Services will be the initial services to be provided by PatentVest and will be conducted in accord with the annual fee. Legal Services will be subject to a separate agreement and are not included herein. These Consulting Services will be provided in accordance with the following terms and conditions:
